Search for: "Pharmaceutical Research and Manufacturers of America" Results 81 - 100 of 410
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2019, 6:21 am
The selected fellow will work with Professor Srividhya Ragavan of the Texas A&M University School of Law and Jonathan Kimball of the Association for Accessible Medicines to produce a white paper that examines the Special 301 submissions of the Pharmaceutical Research and Manufacturers of America to the Office of the U.S. [read post]
29 Sep 2019, 9:05 pm by Cookson Beecher
America’s peanut farmers — through the National Peanut Board — have contributed more than $25.3 million for food allergy research, education and outreach since 2001. [read post]
23 Sep 2019, 5:08 am by Susan Landau
Or compare it with the initial Industrial Revolution, which took about 100 years to occur in Europe and North America. [read post]
16 Sep 2019, 8:57 am
Research suggests that industry reliance on patent protection is lessening. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
  Payors such as PBMs and health insurers obtain rebates on prescription drugs from pharmaceutical manufacturers that have actually inflated the price of drugs and stifled the ability of rival drug manufacturers to effectively compete. [read post]
26 Aug 2019, 12:09 pm
: Copyright and the Court of Justice of the European Union | South African IP researchers’ (AIPLITL) conference report – The IP and IT Law Innovation Interface | Event report - Second IP Researchers Europe Conference in Geneva | Why is there less innovation? [read post]
26 Aug 2019, 5:18 am
The fellow will work closely with Professor Srividhya Ragavan of the Texas A&M University School of Law and Jonathan Kimball of the Association for Accessible Medicines to produce a white paper that examines the Special 301 submissions of the Pharmaceutical Research and Manufacturers of America to the Office of the U.S. [read post]
13 Aug 2019, 6:03 am
: Copyright and the Court of Justice of the European Union | South African IP researchers’ (AIPLITL) conference report – The IP and IT Law Innovation Interface | Event report - Second IP Researchers Europe Conference in Geneva | Why is there less innovation? [read post]
7 Aug 2019, 12:43 am
: Copyright and the Court of Justice of the European Union | South African IP researchers’ (AIPLITL) conference report – The IP and IT Law Innovation Interface | Event report - Second IP Researchers Europe Conference in Geneva | Why is there less innovation? [read post]
29 Jul 2019, 11:01 pm by News Desk
 One target is quality control in the water, pharmaceutical, food, and beverage industries. [read post]
4 Jun 2019, 9:30 pm by Mitra Sharafi
  In both 19th century South Africa (the site of my research) and in 21st century America (where I live and work), law has seemed powerless to prevent rape, as well as inadequate in responding to it. [read post]
8 May 2019, 4:15 pm by Eileen McDermott
The witnesses included two professors, a patient advocate, the Director of South Carolina’s Department of Health and Human Services, and the Executive Vice President and General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA). [read post]
14 Feb 2019, 2:00 am by Tinker Ready
” A brief in support of the limits was filed by industry groups, including the Pharmaceutical Research and Manufacturers of America and the National Association of Manufacturers, with the Chamber of Commerce. [read post]
6 Feb 2019, 6:00 am by Kevin Kaufman
The History and Resurgence of Gross Receipts Taxes Taxes on gross receipts originated in Europe as early as the 13th century.[1] They were an important revenue source for France and Germany in the early 20th century but were later replaced with value-added taxes in the 1960s and 1970s.[2] In America, the first gross receipts tax was established in 1921 by West Virginia as a “business and occupations privilege” tax.[3] Gross receipts taxes spread during the 1930s, as the Great… [read post]
23 Jan 2019, 4:15 am by Sean Hayes
He worked as an interim general manager/HR manager for oil & gas, new tech, pharmaceutical, franchise, and manufacturing companies. [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
Congress included co-pay requirements in the Medicare program, in part, to serve as a check on health care costs, including the prices that pharmaceutical manufacturers can demand for their drugs. [read post]
15 Nov 2018, 9:30 pm by Simone Hussussian
As an alternative to the proposed HHS rule, the Pharmaceutical Research and Manufacturers of America (PhRMA) has published industry-defined guiding principles that recommend that drug manufacturers direct consumers to websites that contain more detailed information about the drug, including prices consumers may be expected to pay. [read post]